Related Experiment Video

Updated: Aug 15, 2026

A Piglet Model of Neonatal Hypoxic-Ischemic Encephalopathy
10:30

A Piglet Model of Neonatal Hypoxic-Ischemic Encephalopathy

Published on: May 16, 2015

Incidence, causes and prognosis of hypotension related to meprobamate poisoning

Cyril Charron1, Armand Mekontso-Dessap, Karim Chergui

  • 1Medical Intensive Care Unit, University Hospital Ambroise Paré, AP/HP, 9 avenue Charles de Gaulle, 92104, Boulogne, France.

Intensive Care Medicine
|October 12, 2005
PubMed
Abstract

Insights

Meprobamate self-poisoning frequently causes hypotension, often linked to cardiac dysfunction. This finding highlights the need for careful monitoring and treatment in affected patients.

Area of Science:

  • Toxicology
  • Cardiology
  • Critical Care Medicine

Background:

  • Meprobamate self-poisoning is a known cause of hypotension.
  • Understanding the cardiac effects of meprobamate overdose is crucial for patient management.

Purpose of the Study:

  • To determine the incidence and causes of hypotension in meprobamate poisoning.
  • To investigate the cardiac function and prognosis in patients with meprobamate-induced hypotension.

Main Methods:

  • Retrospective observational study of 74 patients in a medical ICU requiring mechanical ventilation for meprobamate poisoning.
  • Comparison of demographic, clinical, and laboratory data between hypotensive and non-hypotensive groups.
  • Echocardiographic assessment of left ventricular (LV) and right ventricular (RV) function in hypotensive patients.

Main Results:

  • Hypotension occurred in 40% of patients, with no significant differences in age, gender, or meprobamate levels.
  • Hypotensive patients had lower base excess and echocardiographic evidence of a hypokinetic state with reduced LV ejection fraction and cardiac index.
  • Hypotensive patients required longer ventilation and more frequent inotropic drug infusions.

Conclusions:

  • Meprobamate self-poisoning can induce hypotension, primarily due to cardiac failure, in approximately 40% of cases.
  • This cardiac toxicity necessitates significant therapeutic interventions, including inotropic support.
  • The precise mechanisms of meprobamate's cardiac toxicity and predictive factors remain unclear.

Related Concept Videos

Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Toxidromes: Clinical Features01:30

Toxidromes: Clinical Features

Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...